TS Ipe, AR Davis, JS Raval - Frontiers in Neurology, 2021 - frontiersin.org
Background: Patients with Myasthenia Gravis (MG) can be treated acutely with therapeutic plasma exchange (TPE) or intravenous immune globulin (IVIG). To date, there is no …
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is charged with reviewing, updating and categorizating indications for therapeutic apheresis …
Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged with a review and categorization of indications for therapeutic apheresis. Beginning …
После четвёртого издания этой книги мембранные плазмофильтры и аппаратура продолжали совершенствоваться, и возникла необходимость пятого издания, которое …
A Mandawat, HJ Kaminski, G Cutter, B Katirji… - Annals of …, 2010 - Wiley Online Library
Objective To compare clinical and economic outcomes following plasma exchange (PLEX) and intravenous immunoglobulin (IVIG) in US patients with primary diagnoses of myasthenia …
S Siwachat, A Tantraworasin, W Lapisatepun… - Asian journal of …, 2018 - Elsevier
Background Thymectomy is an effective treatment option for long-term remission of myasthenia gravis. The superiority of the trans-sternal and thoracoscopic surgical …
Abstract The American Society for Apheresis (ASFA) regularly publishes evidence-based guidelines, with the most recent edition in 2016, to assist the requesting and/or apheresis …
J Gamez, M Salvadó, F Carmona… - Therapeutic …, 2019 - journals.sagepub.com
Background: Myasthenic crisis (MC) is a potentially life-threatening complication of myasthenia gravis. Its precipitating factors include surgical procedures, particularly …
A Mandawat, A Mandawat, HJ Kaminski… - Muscle & …, 2011 - Wiley Online Library
Introduction: The purpose of this study was to compare the in‐hospital mortality and complication rates after early and delayed initiation of plasma exchange (PLEX) in patients …